Retour
Fourchette du Jour
10,88 €
11,04 €
Fourchette 52 Semaines
5,30 €
14,85 €
Volume
81 269
Moyenne 50J / 200J
12,40 €
/
9,41 €
Clôture Précédente
10,90 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -12,4 | 0,2 |
| P/B | 1,7 | 3,0 |
| ROE % | -12,0 | 3,6 |
| Net Margin % | -7,9 | 3,8 |
| Rev Growth 5Y % | -0,2 | 9,9 |
| D/E | 1,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,45 €
1,42 € – 1,49 €
|
49,66B | 1 |
| FY2028 |
1,27 €
1,25 € – 1,31 €
|
48,30B | 1 |
| FY2027 |
1,18 €
1,10 € – 1,26 €
|
46,66B | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-04 | 0,10 € | 0,18 € | +86,3% |
| 2025-11-12 | 0,13 € | 0,17 € | +30,8% |
| 2025-08-06 | 0,25 € | 0,35 € | +40,0% |
| 2025-03-05 | 0,28 € | 0,28 € | 0,0% |
| 2024-12-31 | N/A | -0,09 € | — |
| 2024-11-12 | 0,17 € | 0,07 € | -58,8% |
| 2024-08-06 | 0,25 € | 0,25 € | 0,0% |
| 2024-05-14 | 0,46 € | 0,77 € | +68,9% |
Dividend History
7 yr streakYield
0,00%
Payout Ratio
-0,04%
Growth (3Y)
-61,02%
Growth (5Y)
-47,25%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 29, 2025 | May 12, 2025 | 0,03 € | 0,47% |
| Apr 29, 2024 | May 13, 2024 | 0,03 € | 0,40% |
| May 02, 2023 | May 15, 2023 | 0,66 € | 4,18% |
| May 02, 2022 | May 16, 2022 | 0,53 € | 3,33% |
| Apr 28, 2021 | May 10, 2021 | 0,60 € | 3,71% |
| Apr 29, 2020 | May 14, 2020 | 0,76 € | 4,56% |
| Apr 29, 2019 | May 13, 2019 | 0,78 € | 7,14% |
| Jun 22, 2018 | Jul 02, 2018 | 0,42 € | 4,24% |
| May 25, 2018 | Jun 11, 2018 | 0,81 € | 2,76% |
| May 01, 2017 | May 15, 2017 | 2,96 € | 2,42% |
| Apr 27, 2016 | May 12, 2016 | 2,87 € | 2,42% |
| May 22, 2015 | Jun 08, 2015 | 2,46 € | 1,65% |
| Apr 25, 2014 | May 12, 2014 | 2,90 € | 2,23% |
| Apr 24, 2013 | May 09, 2013 | 2,48 € | 2,41% |
| Apr 25, 2012 | May 10, 2012 | 2,15 € | 3,14% |
| Apr 27, 2011 | May 12, 2011 | 2,21 € | 2,66% |
| Apr 28, 2010 | May 13, 2010 | 1,84 € | 2,87% |
| May 08, 2009 | May 26, 2009 | 1,89 € | 3,77% |
| Apr 23, 2008 | May 08, 2008 | 2,10 € | 2,57% |
| Apr 25, 2007 | May 10, 2007 | 1,36 € | 1,99% |
Points Clés
Revenue declined -0,17% annually over 5 years
Generating 2,00B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,90%
Capital efficient — spends only 5,46% of revenue on capex
Croissance
Revenue Growth (5Y)
-0,17%
Revenue (1Y)-6,07%
Earnings (1Y)N/A
FCF Growth (3Y)-8,02%
Qualité
Return on Equity
-12,02%
ROIC7,91%
Net Margin-7,94%
Op. Margin15,26%
Sécurité
Debt / Equity
1,44
Current Ratio1,00
Interest Coverage4,04
Valorisation
P/E Ratio
-12,41
Forward P/E10,00
P/B Ratio1,66
EV/EBITDA11,06
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,07% | Revenue Growth (3Y) | -4,14% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,17% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 43,78B | Net Income (TTM) | -3,48B |
| ROE | -12,02% | ROA | -3,15% |
| Gross Margin | 59,21% | Operating Margin | 15,26% |
| Net Margin | -7,94% | Free Cash Flow (TTM) | 2,00B |
| ROIC | 7,91% | FCF Growth (3Y) | -8,02% |
| Safety | |||
| Debt / Equity | 1,44 | Current Ratio | 1,00 |
| Interest Coverage | 4,04 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | -0,04% |
| Dividend Growth (3Y) | -61,02% | Dividend Growth (5Y) | -47,25% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | -12,41 | Forward P/E | 10,00 |
| P/B Ratio | 1,66 | P/S Ratio | 0,99 |
| PEG Ratio | -0,29 | Forward PEG | N/A |
| EV/EBITDA | 11,06 | Fwd EV/EBITDA | 5,24 |
| Forward P/S | 0,95 | Fwd Earnings Yield | 10,00% |
| FCF Yield | 4,64% | ||
| Market Cap | 43,15B | Enterprise Value | 73,91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43,78B | 46,61B | 47,64B | 50,74B | 44,08B |
| Net Income | -3,48B | -2,55B | -2,94B | 4,15B | 1,00B |
| EPS (Diluted) | -0,88 | -0,65 | -0,75 | 1,06 | 0,26 |
| Gross Profit | 25,92B | 25,34B | 27,89B | 30,87B | 27,27B |
| Operating Income | 6,68B | 3,33B | -150,00M | 6,26B | 6,98B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 110,56B | 110,85B | 116,26B | 124,88B | 120,24B |
| Total Liabilities | 84,51B | 78,81B | 83,18B | 85,95B | 87,07B |
| Shareholders' Equity | 25,94B | 31,91B | 32,93B | 38,77B | 33,02B |
| Total Debt | 37,43B | 40,70B | 44,79B | 41,65B | 39,53B |
| Cash & Equivalents | 6,67B | 6,19B | 5,91B | 5,17B | 4,56B |
| Current Assets | 32,43B | 34,44B | 37,56B | 37,76B | 32,58B |
| Current Liabilities | 32,57B | 28,95B | 29,46B | 35,08B | 29,40B |